Distribution of human papillomavirus genotypes in invasive cervical cancer in Italy: A representative, single institution case series Fulltext Access 4 Pages 2009
Why polio has not been eradicated in India despite many remedial interventions? Fulltext Access 4 Pages 2009
A recombinant DNA and vaccinia virus prime–boost regimen induces potent long-term T-cell responses to HCV in BALB/c mice Fulltext Access 4 Pages 2009
Immunogenicity and safety of diphtheria-tetanus vaccine in pre-adolescent and adolescent South Koreans Fulltext Access 4 Pages 2009
Protection against Yersinia pseudotuberculosis infection conferred by a Lactococcus lactis mucosal delivery vector secreting LcrV Fulltext Access 4 Pages 2009
Do they accept compulsory vaccination?: Awareness, attitudes and behaviour of hospital health care workers following a new vaccination directive Fulltext Access 4 Pages 2009
Evidence of effectiveness from a large county-wide school-based influenza immunization campaign Fulltext Access 4 Pages 2009
Vaccinating against HPV: Physicians’ and medical students’ point of view Fulltext Access 4 Pages 2009
Surveillance of rotavirus in a rural diarrhoea treatment centre in Bangladesh, 2000–2006 Fulltext Access 4 Pages 2009
Long-term persistence of tick-borne encephalitis antibodies in children 5 years after first booster vaccination with Encepur® Children Fulltext Access 4 Pages 2009
Appearance of skin lesions in cattle populations vaccinated against lumpy skin disease: Statutory challenge Fulltext Access 4 Pages 2009
Trivalent inactivated subunit influenza vaccine Influvac®: 25-Year experience of safety and immunogenicity Fulltext Access 4 Pages 2009
Booster vaccination of toddlers with reduced antigen content diphtheria–tetanus–acellular pertussis vaccine Fulltext Access 4 Pages 2009
Incidence of intussusception among children 0–5 years of age in Thailand, 2001–2006 Fulltext Access 4 Pages 2009
Out-of-pocket costs associated with rotavirus gastroenteritis requiring hospitalization in Malaysia Fulltext Access 4 Pages 2009
Rotavirus hospitalization and molecular epidemiology in Northern Japan, 1987–1996 Fulltext Access 4 Pages 2009
Genotyping of rotavirus isolates collected from children less than 5 years of age admitted for diarrhoea at the Yangon Children's Hospital, Myanmar Fulltext Access 4 Pages 2009
Rotavirus diarrhoea among children aged less than 5 years at Mahosot Hospital, Vientiane, Lao PDR Fulltext Access 4 Pages 2009
Hospital-based surveillance for rotavirus diarrhoea in Phnom Penh, Cambodia, March 2005 through February 2007 Fulltext Access 4 Pages 2009
Importance and challenges of accurately counting rotavirus deaths in China, 2002 Fulltext Access 4 Pages 2009
Seroconversion, neutralising antibodies and protection in bluetongue serotype 8 vaccinated sheep Fulltext Access 5 Pages 2009
Differences in the immune response to hepatitis B and Haemophilus influenzae type b vaccines in Guatemalan infants by ethnic group and nutritional status Fulltext Access 5 Pages 2009
Novel Adenovirus type 5 vaccine platform induces cellular immunity against HIV-1 Gag, Pol, Nef despite the presence of Ad5 immunity Fulltext Access 5 Pages 2009
Vaxfectin®, a cationic lipid-based adjuvant for protein-based influenza vaccines Fulltext Access 5 Pages 2009
Respiratory syncytial virus subunit vaccine based on a recombinant fusion protein expressed transiently in mammalian cells Fulltext Access 5 Pages 2009
A methodological approach to scaling up fermentation and primary recovery processes to the manufacturing scale for vaccine production Fulltext Access 5 Pages 2009
Human papillomavirus immunisation of adolescent girls and anticipated reporting of immune-mediated adverse events Fulltext Access 5 Pages 2009
Singaporean men's knowledge of cervical cancer and human papillomavirus (HPV) and their attitudes towards HPV vaccination Fulltext Access 5 Pages 2009
Sequence analysis of Bs-Ag2 gene from Baylisascaris schroederi of giant panda and evaluation of the efficacy of a recombinant Bs-Ag2 antigen in mice Fulltext Access 5 Pages 2009
BCG vaccination reduces risk of infection with Mycobacterium tuberculosis as detected by gamma interferon release assay Fulltext Access 5 Pages 2009
Monitoring adverse events following yellow fever vaccination using an integrated telephone and Internet-based system Fulltext Access 5 Pages 2009
Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus Fulltext Access 5 Pages 2009
Identification of a surface protective antigen, HP0197 of Streptococcus suis serotype 2 Fulltext Access 5 Pages 2009
A single immunization with a recombinant canine adenovirus type 2 expressing the seoul virus Gn glycoprotein confers protective immunity against seoul virus in mice Fulltext Access 5 Pages 2009
Recent advances in the study of human antibody responses to influenza virus using optimized human hybridoma approaches Fulltext Access 5 Pages 2009
Validity of self-reported pneumococcal vaccination status in the elderly in Spain Fulltext Access 5 Pages 2009
The TLR9 agonist CpG fails to enhance the acquisition of Plasmodium falciparum-specific memory B cells in semi-immune adults in Mali Fulltext Access 5 Pages 2009
Infection with a low virulent Mycoplasma hyopneumoniae isolate does not protect piglets against subsequent infection with a highly virulent M. hyopneumoniae isolate Fulltext Access 5 Pages 2009
Impact of measles outbreak response vaccination campaign in Dar es Salaam, Tanzania Fulltext Access 5 Pages 2009
Antibody response following hepatitis B vaccination in dialysis patients: Does depression and life quality matter? Fulltext Access 5 Pages 2009
Seroprevalence of antibodies against fHbp and NadA, two potential vaccine antigens for Neisseria meningitidis Fulltext Access 5 Pages 2009
Characterization of recombinant influenza A virus as a vector for HIV-1 p17Gag Fulltext Access 5 Pages 2009
Effectiveness of inactivated influenza vaccine in children less than 5 years of age over multiple influenza seasons: A case–control study Fulltext Access 5 Pages 2009
Group B streptococcal conjugate vaccines elicit functional antibodies independent of strain O-acetylation Fulltext Access 5 Pages 2009
Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders Fulltext Access 5 Pages 2009
Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus Fulltext Access 5 Pages 2009
Leadership in Immunization: The relevance to Japan of the U.S.A. experience of the Centers for Disease Control and Prevention (CDC) and the Advisory Committee on Immunization Practices (ACIP) Fulltext Access 5 Pages 2009
Importance of subunit vaccine antigen of major Fli C antigenic site of Salmonella Enteritidis II: A challenge trial Fulltext Access 5 Pages 2009
Reasons for non-adherence to vaccination at mother and child care clinics (MCCs) in Lambaréné, Gabon Fulltext Access 5 Pages 2009
Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans Fulltext Access 5 Pages 2009
A four-stage strategy to reduce childhood pneumonia-related mortality by 2015 and beyond Fulltext Access 5 Pages 2009
Long-term efficacy of plasma-derived and recombinant hepatitis B vaccines in a rural township of Central Taiwan Fulltext Access 5 Pages 2009
A single-dose combination therapy that both prevents and treats anthrax infection Fulltext Access 5 Pages 2009
Human papillomavirus vaccine decision-making in Da Nang, Vietnam: Perceived spousal and adolescent–parent concordance Fulltext Access 5 Pages 2009
Issues in pneumococcal disease and pneumococcal conjugate vaccines: Highlights of the 27th meeting of ESPID, Brussels, Belgium, June 9–13, 2009 Fulltext Access 5 Pages 2009
Cost-effectiveness of a 3-dose pneumococcal conjugate vaccine program in the province of Quebec, Canada Fulltext Access 5 Pages 2009
Inactivated influenza vaccine effectiveness against influenza-like illness among young children in Japan—With special reference to minimizing outcome misclassification Fulltext Access 5 Pages 2009
Field experimental vaccination campaigns against myxomatosis and their effectiveness in the wild Fulltext Access 5 Pages 2009
Co-administration of inactivated avian influenza virus with CpG or rIL-2 strongly enhances the local immune response after intranasal immunization in chicken Fulltext Access 5 Pages 2009
Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice Fulltext Access 5 Pages 2009
Vaccination as infection control: A pilot study to determine the impact of Staphylococcus aureus vaccination on nasal carriage Fulltext Access 5 Pages 2009
Identification of potent biodegradable adjuvants that efficiently break self-tolerance—A key issue in the development of therapeutic vaccines Fulltext Access 5 Pages 2009
Nanoparticle formulated alpha-galactosylceramide activates NKT cells without inducing anergy Fulltext Access 5 Pages 2009
Protective efficacy of bacterial membranes containing surface-exposed BM95 antigenic peptides for the control of cattle tick infestations Fulltext Access 5 Pages 2009
Determinants of non-compliance with herpes zoster vaccination in the community-dwelling elderly Fulltext Access 5 Pages 2009
Efficacy of bp26 and bp26/omp31 B. melitensis Rev.1 deletion mutants against Brucella ovis in rams Fulltext Access 5 Pages 2009
Joint reviews and inspections: Strategic forms of collaboration for strengthening the regulatory oversight of vaccine clinical trials in Africa Fulltext Access 5 Pages 2009
Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep Fulltext Access 5 Pages 2009
Immune responses in the airways by nasal vaccination with systemic boosting against Pseudomonas aeruginosa in chronic lung disease Fulltext Access 5 Pages 2009
Protection in mice immunized with a heterologous prime-boost regime using DNA and recombinant pseudorabies expressing TgSAG1 against Toxoplasma gondii challenge Fulltext Access 5 Pages 2009
Commonly administered BCG strains including an evolutionarily early strain and evolutionarily late strains of disparate genealogy induce comparable protective immunity against tuberculosis Fulltext Access 5 Pages 2009
Risk factors for nosocomial rotavirus infection in a paediatric hospital: The potential role for rotavirus vaccine use Fulltext Access 5 Pages 2009
The effect of 23-valent pneumococcal polysaccharide vaccine on immunological priming induced by 7-valent conjugate vaccine in asplenic subjects with β-thalassemia Fulltext Access 5 Pages 2009
Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults Fulltext Access 5 Pages 2009
Mucosal perspectives in pneumococcal vaccine development: A meeting summary Fulltext Access 5 Pages 2009
Economic benefits for the family of inactivated subunit virosomal influenza vaccination of healthy children aged 3–14 years during the annual health examination in private paediatric offices Fulltext Access 5 Pages 2009
Detection of LP2086 on the cell surface of Neisseria meningitidis and its accessibility in the presence of serogroup B capsular polysaccharide Fulltext Access 5 Pages 2009
Heterogeneous in vivo expression of clumping factor A and capsular polysaccharide by Staphylococcus aureus: Implications for vaccine design Fulltext Access 5 Pages 2009
Trends affecting the future of vaccine development and delivery: The role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics Fulltext Access 5 Pages 2009
Field efficacy trial of a novel HVT-IBD vector vaccine for 1-day-old broilers Fulltext Access 5 Pages 2009
Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages Fulltext Access 5 Pages 2009
Simplifying paediatric immunization with a fully liquid DTP–HepB–Hib combination vaccine: Evidence from a comparative time-motion study in India Fulltext Access 5 Pages 2009
MALVAC 2008: Measures of efficacy of malaria vaccines in phase 2b and phase 3 trials—Scientific, regulatory and public health perspectives Fulltext Access 5 Pages 2009